Ang-II	angiotensin II
BP	blood pressure
BPA	bisphenol A
BPAF	bisphenol AF
BPC	bisphenol C
Ca2+	calcium
CAD	coronary artery disease
CnAβ	calcineurin
CVDs	cardiovascular diseases
DCM	dilated cardiomyopathy
DRP1	dynamin-related protein 1
EC	endothelial cells
EDC	endocrine-disrupting compound;
EDHF	endothelium-derived hyperpolarizing factor
ER	estrogen receptors
ET-1	endothelin 1
GPR30	G-protein-coupled estrogen receptor
HDPs	hypertensive disorders of pregnancy
HEK	human embryonic kidney
hiPSC-CMs	human-induced pluripotent stem-cell-derived cardiomyocytes
HRV	heart rate variability
HUVECs	human umbilical vein endothelial cells
IC50	half-maximal inhibitory concentration
iPSCs	induced pluripotent stem cells
IR	ischemia–reperfusion
K+	potassium
MAP	mean atrial pressures
MBP	4-Methyl-2,4-bis(p-hydroxyphenyl)pent-1-ene
MI	myocardial infarction
MOA	mechanisms of action
Na+	sodium
NHANES	National Health and Nutrition Examination Survey
NO	nitric oxide
PAD	peripheral artery disease
PE	preeclampsia
PFOS	perfluorooctane sulfonate;
PGI-2	prostacyclin
PLB	phospholamban
PPAR-γ	peroxisome proliferator-activated receptor gamma
RIP3	Rat Receptor-Interacting Protein 3
SMC	smooth muscle cells
TxA2	thromboxane
U.S.	United States
XME	xenobiotic-metabolizing enzymes